Recently, a more advanced RNA
interference (RNAi)-based biotechnology
was developed in the author’s laboratory at
the National Institute of Biotechnology at
Ben Gurion University (BGU) of the
Negev in Israel. It is based on the recent
finding of a patented new gene encoding
an insulin-like androgenic gland hormone
from M. rosenbergii termed Mr-IAG.